Theranexus Société Anonyme (EPA:ALTHX)
2.280
-0.070 (-2.98%)
Sep 26, 2025, 5:35 PM CET
EPA:ALTHX Revenue
Theranexus Société Anonyme had revenue of 817.00K EUR in the half year ending June 30, 2025, with 234.38% growth. This brings the company's revenue in the last twelve months to 879.38K, down -61.18% year-over-year. In the year 2024, Theranexus Société Anonyme had annual revenue of 2.28M with 670.55% growth.
Revenue (ttm)
879.38K
Revenue Growth
-61.18%
P/S Ratio
22.13
Revenue / Employee
87.94K
Employees
10
Market Cap
19.46M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.28M | 1.99M | 670.55% |
Dec 31, 2023 | 296.33K | -118.57K | -28.58% |
Dec 31, 2022 | 414.90K | 414.30K | 68,819.93% |
Dec 31, 2021 | 602.00 | -294.01K | -99.80% |
Dec 31, 2020 | 294.61K | -269.24K | -47.75% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 27.24B |
Sanofi | 45.74B |
Sartorius Stedim Biotech | 2.90B |
bioMérieux | 4.12B |
Eurofins Scientific SE | 7.14B |
Ipsen | 3.76B |
ABIVAX Société Anonyme | 6.02M |
Virbac | 1.43B |